P.2.b.016 Efficacy and safety of vilazodone 20 mg and 40 mg in major depressive disorder (MDD): a randomised, double-blind, placebo- and active-controlled trial

2014 ◽  
Vol 24 ◽  
pp. S386-S387
Author(s):  
A. Khan ◽  
C. Gommoll ◽  
M. Mathews ◽  
D. Chen ◽  
R. Nunez
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder

2018 ◽  
Vol 6 (5) ◽  
pp. 1604-1612 ◽  
Author(s):  
E. Sherwood Brown ◽  
Nasreen Sayed ◽  
Erin Van Enkevort ◽  
Alexandra Kulikova ◽  
Alyson Nakamura ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

2013 ◽  
Vol 74 (07) ◽  
pp. e636-e641 ◽  
Author(s):  
Cristina Cusin ◽  
Nadia Iovieno ◽  
Dan V. Iosifescu ◽  
Andrew A. Nierenberg ◽  
Maurizio Fava ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Treatment Resistant ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document